Unique Digital Images as Incentives in Clinical Trials: A Digital Shift Toward Meaningful Participation - Takeaways - MDSpire

Unique Digital Images as Incentives in Clinical Trials: A Digital Shift Toward Meaningful Participation

  • By

  • Xavier Tadeo

  • Gyula Seres

  • Peter Wang

  • Yoann Sapanel

  • Alexandria Remus

  • Jasmine L Eyal

  • Jason Kai-Wei Lee

  • Simon Chesterman

  • Julian Savulescu

  • John Eu-Li Wong

  • Christopher L Asplund

  • R Brian Stone

  • Benjamin C K Tee

  • Reza Shokri

  • Marlena Raczkowska

  • Li Ming Chong

  • Siong Peng Kwek

  • Agata Blasiak

  • Dean Ho

  • June 8, 2026

  • 0 min

Share

  • 1

    Recruitment and retention challenges significantly hinder clinical trials, leading to increased costs and wasted data.

  • 2

    Traditional monetary and nonmonetary incentives often fail to improve participant engagement in clinical research.

  • 3

    Digital artwork as a personalized incentive may enhance participant motivation by fostering a sense of identity and contribution.

  • 4

    The integration of digital health tools and patient-facing infrastructure supports the feasibility of innovative incentive models.

  • 5

    A forthcoming feasibility study, Avatar.DTx, will explore the use of digital images as participation incentives in clinical trials.

Original Source(s)

Unique Digital Images as Incentives in Clinical Trials: A Digital Shift Toward Meaningful Participation

  • by Xavier Tadeo, Gyula Seres, Peter Wang, Yoann Sapanel, Alexandria Remus, Jasmine L Eyal, Jason Kai-Wei Lee, Simon Chesterman, Julian Savulescu, John Eu-Li Wong, Christopher L Asplund, R Brian Stone, Benjamin C K Tee, Reza Shokri, Marlena Raczkowska, Li Ming Chong, Siong Peng Kwek, Agata Blasiak, Dean Ho

  • June 8, 2026

Related Content

Can AI Break the “Measurement Paradigm?”

Congo Ebola Outbreak Strains Care Delivery

“We live with fear in our stomachs"

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.